LLY stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
Ricks David A2023/03/21SVP and Pres, Lilly Bio-Meds170728-408462023-03-2100000594780000059478129882
-
Hedley Mary Lynne2023/03/20512023-03-200000059478000005947851
-
Hedley Mary Lynne2023/03/19512023-03-190000059478000005947851
-
Hedley Mary Lynne2023/03/18512023-03-180000059478000005947851
-
Hedley Mary Lynne2023/03/17512023-03-170000059478000005947851
-
Hedley Mary Lynne2023/03/16512023-03-160000059478000005947851
-
Ricks David A2023/03/15SVP and Pres, Lilly Bio-Meds170728-408462023-03-1500000594780000059478129882
-
Tapiero Jacques2023/03/14SVP&Pres.-Emerging Markets BU148822023-03-140000059478000005947814882
-
Hedley Mary Lynne2023/03/13512023-03-130000059478000005947851
-
Zakrowski Donald A2023/03/12Chief Accounting Officer46594-272002023-03-120000059478000005947819394
Related News

ASML Stock Falls 14% Since February High—Can NASDAQ:ASML Reclaim Its Uptrend?
TradingNEWS Archive
28.04.25

Tesla (NASDAQ:TSLA) Advances to $295.50 on Full Self-Driving Gains and Production Efficiencies
TradingNEWS Archive
28.04.25

Pfizer Stock at $22.50—Could That 7.6% Yield and a $64 B Revenue Outlook Turn PFE Around?
TradingNEWS Archive
25.04.25